Join
Live feed
·
INSIDERFilingvia Quantisnow
Agios Pharmaceuticals Inc. logo

Chief Executive Officer Goff Brian converted options into 22,691 shares and sold $406,487 worth of shares (11,085 units at $36.67), increasing direct ownership by 10% to 123,528 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGIO (Agios Pharmaceuticals Inc.) and more on Quantisnow.